These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15131036)

  • 1. Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer.
    Tsujimoto Y; Tomita Y; Hoshida Y; Kono T; Oka T; Yamamoto S; Nonomura N; Okuyama A; Aozasa K
    Clin Cancer Res; 2004 May; 10(9):3007-12. PubMed ID: 15131036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
    Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.
    Yamamoto S; Tomita Y; Nakamori S; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M; Aozasa K
    J Clin Oncol; 2003 Feb; 21(3):447-52. PubMed ID: 12560433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis.
    Yamamoto S; Tomita Y; Hoshida Y; Sakon M; Kameyama M; Imaoka S; Sekimoto M; Nakamori S; Monden M; Aozasa K
    Clin Cancer Res; 2004 Jan; 10(2):651-7. PubMed ID: 14760088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms.
    Yamamoto S; Tomita Y; Nakamori S; Hoshida Y; Iizuka N; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Aozasa K; Monden M
    Oncology; 2004; 66(6):468-75. PubMed ID: 15452376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
    J Clin Oncol; 2003 Jul; 21(13):2537-44. PubMed ID: 12829673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
    Ann Surg Oncol; 2004 Feb; 11(2):165-72. PubMed ID: 14761919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Toyosawa S; Inohara H; Kishino M; Kogo M; Nakazawa M; Murakami S; Iizuka N; Kidogami S; Monden M; Kubo T; Ijuhin N; Aozasa K
    Ann Oncol; 2004 Sep; 15(9):1432-8. PubMed ID: 15319251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
    Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K
    Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Monden M; Yamamoto S; Iuchi K; Aozasa K
    Ann Surg Oncol; 2004 Jul; 11(7):697-704. PubMed ID: 15231524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression.
    Duscharla D; Reddy Kami Reddy K; Dasari C; Bhukya S; Ummanni R
    J Cell Physiol; 2018 Oct; 233(10):7148-7164. PubMed ID: 29693262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valosin-containing protein (VCP/p97)-expression correlates with prognosis of HPV- negative oropharyngeal squamous cell carcinoma (OSCC).
    Meyer MF; Seuthe IM; Drebber U; Siefer O; Kreppel M; Klein MO; Mikolajczak S; Klussmann JP; Preuss SF; Huebbers CU
    PLoS One; 2014; 9(12):e114170. PubMed ID: 25463965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression level of valosin containing protein is associated with prognosis of primary orbital MALT lymphoma.
    Zhu WW; Kang L; Gao YP; Hei Y; Dong J; Liu Y; Xiao LH; Yang G
    Asian Pac J Cancer Prev; 2013; 14(11):6439-43. PubMed ID: 24377547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
    Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
    Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma.
    Cui Y; Niu M; Zhang X; Zhong Z; Wang J; Pang D
    Tumour Biol; 2015 Dec; 36(12):9919-27. PubMed ID: 26168958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma.
    Qiu Y; Wang ZL; Jin SQ; Pu YF; Toyosawa S; Aozasa K; Morii E
    J Zhejiang Univ Sci B; 2012 Mar; 13(3):168-75. PubMed ID: 22374608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
    Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
    Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
    Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
    BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
    Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
    Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
    Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
    Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.